Argenx presents new efgartigimod data at EULAR 2025 - PharmaTimes Rheumatology studies show promising results for Sjogren’s disease

#pharmaceuticals #Rheumatology #NeuromuscularDisease #Argenx #efgartigimod #efgartigimoddata #EULAR2025 #Sjogrensdisease #myositis #FastTrackdesignation #primarySjogrensdisease #ALKIVIAstudy #myositispatients #FcRninhibitor #UNITYtrial
pharmatimes.com/news/argenx-...

Alexandra Calmy excellent on doing trials during epidemics and what to do when other trials find no benefit

Like Tecovirimat for #mpox #UnityTrial 🇨🇭 🇧🇷 🇦🇷

Agree with rationale for continuing trial to reach enrolment 🎯

@gcevd.bsky.social @eckerleisabella.bsky.social